Immediate Single Stage Implant-based Breast Reconstruction with or Without TIGR Mesh in Iranian Patients Undergoing Mastectomy: A Quasi-experimental Study

IF 0.4 Q4 ONCOLOGY International Journal of Cancer Management Pub Date : 2023-05-30 DOI:10.5812/ijcm-130547
N. Nafissi, A. Bagheri, H. Vaseghi, Leyla Shojaee, Mina Zolnouri, S. Pompei, Batool Tayefi
{"title":"Immediate Single Stage Implant-based Breast Reconstruction with or Without TIGR Mesh in Iranian Patients Undergoing Mastectomy: A Quasi-experimental Study","authors":"N. Nafissi, A. Bagheri, H. Vaseghi, Leyla Shojaee, Mina Zolnouri, S. Pompei, Batool Tayefi","doi":"10.5812/ijcm-130547","DOIUrl":null,"url":null,"abstract":"Background: Breast cancer is still a major contributing factor to the burden of the disease worldwide. A single-stage implant-based reconstruction (IBR) lowers tissue morbidity, thus increasing overall aesthetic outcome and patient satisfaction. Objectives: Because of the high price of ADM and the lack of insurance coverage in Iran, we aimed at examining the results of using TIGR® mesh in patients with breast cancer. Methods: This quasi-experimental study was conducted in Iran (Tehran) from 2016 to 2018. About 140 eligible patients with breast cancer were included and their information was collected and analyzed prospectively during the 3 years that they were referred to the surgery center in Tehran. The reconstruction was performed, as either direct-single staged, Implant + TIGR MESH, or delayed-multistage. Patient satisfaction was calculated after 1 year of follow-up, using Body Checking Questionnaire (BCQ) by applying the VAS scale. All statistical analyses were performed at a 95% significance level, using SPSS statistical software version. (Evidence-based medicine level: Level III, a prospective cohort). Results: The results of our study showed slightly more short-term complications than other studies due to the surgical team’s first experience in the surgery. Complications were infection (7.1%), epidermal necrosis (15.9%), and severe capsular contracture (14.2%). Seven patients (6.2%) had full-thickness skin necrosis, and the prosthesis was finally removed. The use of the TIGR Mesh did not increase the rate of complications, and only 5 implant losses in this group and 2 in the tissue expander group were reported. The levels of patients’ satisfaction in IBR and delayed-multistage groups were 44.4% and 12.7%, respectively. Conclusions: Our results showed that placement of TIGR MESH for lower pole support during IBR does not increase the complication rate. Additionally, patients’ satisfaction levels increased compared to traditional methods of reconstruction.","PeriodicalId":44764,"journal":{"name":"International Journal of Cancer Management","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/ijcm-130547","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Breast cancer is still a major contributing factor to the burden of the disease worldwide. A single-stage implant-based reconstruction (IBR) lowers tissue morbidity, thus increasing overall aesthetic outcome and patient satisfaction. Objectives: Because of the high price of ADM and the lack of insurance coverage in Iran, we aimed at examining the results of using TIGR® mesh in patients with breast cancer. Methods: This quasi-experimental study was conducted in Iran (Tehran) from 2016 to 2018. About 140 eligible patients with breast cancer were included and their information was collected and analyzed prospectively during the 3 years that they were referred to the surgery center in Tehran. The reconstruction was performed, as either direct-single staged, Implant + TIGR MESH, or delayed-multistage. Patient satisfaction was calculated after 1 year of follow-up, using Body Checking Questionnaire (BCQ) by applying the VAS scale. All statistical analyses were performed at a 95% significance level, using SPSS statistical software version. (Evidence-based medicine level: Level III, a prospective cohort). Results: The results of our study showed slightly more short-term complications than other studies due to the surgical team’s first experience in the surgery. Complications were infection (7.1%), epidermal necrosis (15.9%), and severe capsular contracture (14.2%). Seven patients (6.2%) had full-thickness skin necrosis, and the prosthesis was finally removed. The use of the TIGR Mesh did not increase the rate of complications, and only 5 implant losses in this group and 2 in the tissue expander group were reported. The levels of patients’ satisfaction in IBR and delayed-multistage groups were 44.4% and 12.7%, respectively. Conclusions: Our results showed that placement of TIGR MESH for lower pole support during IBR does not increase the complication rate. Additionally, patients’ satisfaction levels increased compared to traditional methods of reconstruction.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
伊朗乳房切除术患者使用或不使用TIGR补片的即时单期假体乳房重建:一项准实验研究
背景:乳腺癌仍然是世界范围内造成疾病负担的一个主要因素。单阶段植入式重建(IBR)降低了组织发病率,从而提高了整体美学结果和患者满意度。目的:由于ADM的高价格和伊朗缺乏保险覆盖,我们旨在研究在乳腺癌患者中使用TIGR网片的结果。方法:2016 - 2018年在伊朗(德黑兰)进行准实验研究。大约140名符合条件的乳腺癌患者被纳入研究,他们的信息被收集,并在他们被转介到德黑兰手术中心的三年内进行前瞻性分析。重建分为直接单阶段、种植体+ TIGR MESH或延迟多阶段。随访1年后,采用身体检查问卷(BCQ),采用VAS量表计算患者满意度。所有统计分析均采用SPSS统计软件,在95%显著性水平下进行。(循证医学水平:III级,前瞻性队列)。结果:我们的研究结果显示,由于手术团队的首次手术经验,短期并发症略多于其他研究。并发症为感染(7.1%)、表皮坏死(15.9%)和严重包膜挛缩(14.2%)。7例(6.2%)患者出现全层皮肤坏死,最终切除假体。使用TIGR Mesh没有增加并发症的发生率,仅报告了该组5例种植体丢失,组织扩张器组2例。IBR组和延迟多期组患者满意度分别为44.4%和12.7%。结论:我们的研究结果表明,在IBR期间放置TIGR MESH作为下极支持不会增加并发症发生率。此外,与传统的重建方法相比,患者的满意度也有所提高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
67
期刊介绍: International Journal of Cancer Management (IJCM) publishes peer-reviewed original studies and reviews on cancer etiology, epidemiology and risk factors, novel approach to cancer management including prevention, diagnosis, surgery, radiotherapy, medical oncology, and issues regarding cancer survivorship and palliative care. The scope spans the spectrum of cancer research from the laboratory to the clinic, with special emphasis on translational cancer research that bridge the laboratory and clinic. We also consider original case reports that expand clinical cancer knowledge and convey important best practice messages.
期刊最新文献
Assessing Analgesic Adherence and Influencing Factors in Saudi Cancer Patients Research Progress of Idiopathic Pulmonary Fibrosis Complicated with Lung Cancer Microvessel Density Assessment and Related Factors in Patients with Endometrial Cancer: A Cross-Sectional Study Challenges of Truth-telling to Patients and Their Families: A Qualitative Study Continued Increase in Incidence of Kidney Cancer in Iran and its 31 Provinces
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1